Skip to main content
    O

    Omnicell Inc (OMCL)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $35.44
    +0.41 (+1.17%)

    Market Cap: $1.61B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Omnicell Inc (OMCL) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Omnicell (OMCL) to earn $2.48 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.23B. Of 8 analysts, 7 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $2.01.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 88% of the ratings.

    RatingAnalystsShare
    Strong Buy112.5%
    Buy675.0%
    Hold112.5%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    8

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus falls 19.0% and revenue estimates rise 0.8%.

    Fiscal year ending Dec 31, 2026
    $2.48
    EPS consensus, revenue $1.23B
    Fiscal year ending Dec 31, 2027
    $2.01
    EPS consensus, revenue $1.24B
    Next report
    Feb 3, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$2.48$2.45 to $2.528$1.23B$1.23B to $1.23B8
    Dec 31, 2027$2.01$1.59 to $2.418$1.24B$1.23B to $1.25B8

    Quarterly Estimates

    The EPS consensus rises from $0.39 for the quarter ending Dec 31, 2026 to $0.45 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.39$0.14 to $0.4510$304.53M$290.52M to $315.95M10
    Mar 31, 2027$0.45$0.33 to $0.627$304.51M$298.92M to $312.02M7

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 7 upward and 8 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202735
    Quarter ending Mar 31, 202743

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 8.8% from $2.28.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$2.48$2.28$2.28$2.28$2.28+8.7%
    Fiscal year ending Dec 31, 2027$2.01$2.06$2.09$2.09$2.09-3.9%
    Quarter ending Mar 31, 2027$0.45$0.44$0.44$0.44$0.44+2.3%

    Frequently Asked Questions About OMCL

    What is the OMCL stock forecast?

    Consensus analyst estimates put Omnicell's EPS at $2.48 for the fiscal year ending Dec 31, 2026, on revenue of $1.23B. The consensus rating from 8 analysts is Buy.

    How do analysts rate OMCL stock?

    Of 8 analysts covering Omnicell, 1 rates it Strong Buy, 6 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from OMCL next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.48, with estimates from $2.45 to $2.52 from 8 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.01, with estimates from $1.59 to $2.41 from 8 analysts.

    What revenue do analysts expect from Omnicell next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.23B, with estimates from $1.23B to $1.23B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.24B, with estimates from $1.23B to $1.25B.

    How many analysts cover OMCL?

    8 analysts rate Omnicell stock, and 8 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.